Aging Outside the Box - PowerPoint PPT Presentation

1 / 34
About This Presentation
Title:

Aging Outside the Box

Description:

Title: Vision and Opportunity Author: Immunology/Rheumatology Last modified by: Leslie Lindzey Created Date: 1/22/2005 12:05:39 AM Document presentation format – PowerPoint PPT presentation

Number of Views:61
Avg rating:3.0/5.0
Slides: 35
Provided by: Immuno2
Category:

less

Transcript and Presenter's Notes

Title: Aging Outside the Box


1
Aging Outside the Box
  • Stanford Continuing Studies
  • James F. Fries, MD
  • November 7, 2007
  • Slides Available at ARAMIS.Stanford.edu

2
Class Schedule
  • General Themes
  • October 17 Longevity
  • October 24 Compression of Morbidity
  • October 31 Declining Disability
  • November 7 Aging and Health Policy
  • December 5 Synthesis and Application

3
For a Letter Grade
  • Pick an article, any article, from the course
    reader.
  • Write a page, double-spaced, bullets allowed, on
    Why you should believe this paper
  • Write a second page on Why you should not
    believe this paper.
  • Email to jff_at_stanford.edu or mail to J. F. Fries,
    1000 Welch Road, Suite 203, Stanford, CA 94304
  • Be ready to say a few words about your arguments
    at the last class meeting December 5

4
(No Transcript)
5
(No Transcript)
6
National Long-Term Care SurveysDisability
Percentages Over Age 65
1982 1989 1994 1999 2004

Disabled, Any 26.5 24.8 23.2 21.2 19.0
Mild Disability (IADL) 5.7 4.5 4.4 3.3 2.4
Moderate Disability 6.8 6.6 6.1 6.3 5.6
Severe Disability 3.5 3.1 2.9 3.0 3.2

Institutionalized 7.5 6.9 6.3 4.9 4.0
Manton and Gu, 2006
7
Recent Trends in Disability Among Older Americans
8
Percentage of Disability Over Time Estimates by
Age Groups, NLTCS 1982-2004
Age Disability Level 1982 1989 1994 1999 2004 Relative Changes,
Age 65-74
Disabled 14.2 11.9 11.8 10.7 8.9 -37.3
Institution 2.0 1.9 1.6 1.4 0.9 -54.6
Age 75-84
Disabled 30.7 29.4 26.2 23.4 21.9 -28.7
Institution 8.1 7.0 6.3 4.3 4.1 -48.8
Age 85
Disabled 62.1 61.4 58.5 55.6 49.7 -20.0
Institution 27.2 26.1 24.6 19.5 15.6 -42.7
9
Average Medicare Part A expenditures by
disability category and year (in 2004 dollars,
000s per person)
Age and disability level 1982 1989 1994 1999 2004
Total
Nondisabled 2.2 2.0 1.9 1.7 1.6
Five or six ADL 15.2 11.9 17.7 13.6 12.0
Institution 8.5 7.9 8.6 10.1 9.8
Age 65-84
Nondisabled 2.2 1.9 1.9 1.7 1.5
Five or Six ADL 17.4 11.7 10.5 14.9 12.5
Institution 9.8 9.3 6.6 12.8 10.8
Age 85
Nondisabled 2.9 2.8 2.0 2.6 2.3
Five or six ADL 8.4 12.4 17.4 11.1 10.9
Institution 6.7 6.0 7.1 7.3 8.8
10
Causes of Disability Decline
  • Have to (1) have greatly increased in use since
    1982, (2) apply to a lot of people, (3) have a
    substantial effect on disability in those people,
    and, preferably, (4) not have a large effect on
    increasing life expectancy
  • Lifestyle smoking down, obesity up, exercise
    flat
  • Medical anti-hypertensives, statins, low-dose
    aspirin, diabetes control, total joint
    replacement
  • Social second-hand smoke, highways, air bags

11
Total Joint Replacement Contributes to Declining
Disability Rates in Seniors
  • James F. Fries, M.D.
  • Eliza F. Chakravarty, M.D.
  • Bharathi Lingala, Ph.D.
  • Helen H. Hubert, Ph.D.
  • Stanford University, Stanford CA

12
Objective
  • The National Long-Term Care Survey documented a
    nearly 2 annual decline in disability rates
    among seniors (age 65 years) from 1982 to 2004
  • Objective To estimate how much of the national
    decline may be attributed to knee and hip joint
    replacement (TJR)

Manton KG, et al. PNAS 200610318374.
13
Assumptions
  • Observed decrease in disability is linear
  • TJR has no significant effect on mortality
  • Impact of TJR on disability remains constant over
    time
  • Duration of effect of TJR is 10 years
  • Benefit from individual TJR procedures is
    constant from 1982 to 2004

14
Sources of Data
  • U.S. population 65 years US. Census
  • TJRs performed National Hospital Discharge
    Survey (CDC)
  • Baseline disability (Health Assessment
    Questionnaire-Disability Index) ARAMIS dataset
  • Disability improvement at 7-12 months following
    TJR (HAQ-DI) ARAMIS dataset

15
Statistics
  • Cohort study All ARAMIS participants who
    underwent TJR with HAQ-DI scores before and after
    compared with 12-month change data in
    participants without TJR.
  • Case-Control study ARAMIS participants with TJR
    compared to controls matched on age (same year),
    gender, and baseline HAQ-DI (exact). Pair-wise
    t-tests
  • Extrapolation Change in HAQ-DI prior to TJR
    extrapolated out 12 months and compared to
    observed HAQ-DI 12 months post TJR

16
TJR rates by Year
17
Change in disability/pain over one year for
subjects with TJR
p lt 0.05 p lt 0.01 p lt 0.001
18
Change in disability/Pain over one year without
TJR
p lt 0.01 p lt 0.001
19
Case/Control Analysis
Matched for age (year), gender, and HAQ-DI (exact)
20
12-month disability 1.74 expected HAQ-DI -1.46
observed HAQ-DI 0.28 HAQ-DI Units
21
Figure 2
12-month pain 2.20 expected score -1.32
observed score 0.88 units
22
Summary
Study Design Outcome Variable Baseline Value Change Score
Cohort HAQ-DI 1.46 -0.10
Pain 1.73 -0.47
Case-Control HAQ-DI 1.24 -0.14
Pain 1.56 -0.30
Extrapolation HAQ-DI 1.51 -0.28
Pain 1.75 -0.88
Four-fold increase in TJR in seniors from
1982-2004
23
Master Equation
  • Change in Nationwide disability due to TJR
  • (? HAQ/ Baseline HAQ) x cumulative proportion
    with TJR x duration of response
  • (0.10/1.5) x 0.12 x 10 years
  • 0.08 reduction in disability attributable to
    TJR
  • 4.0 of the 2 decline in nationwide disability

24
Sensitivity Analyses
? HAQ Baseline HAQ TJR In pop. Duration (Years) ? Disability of Change
0.10 1.5 12 10 0.08 4
0.10 1.0 12 10 0.12 6
0.10 1.5 12 5 0.04 2
0.10 1.5 12 15 0.12 6
0.15 1.5 12 10 0.12 6
0.15 1.0 12 10 0.18 9
0.15 1.5 12 5 0.06 3
0.25 1.5 12 10 0.45 22
25
Conclusions
  • TJR has made a small but detectable impact on
    national disability rates
  • The benefits of TJR are greater in the pain
    domain than in disability reduction
  • Different approaches to estimating the disability
    reduction yield reasonably similar estimates
  • Approximately 2-8 of the national disability
    decline since 1982 is attributable to increased
    numbers of knee and hip replacement operations

26
Health Improvement Programs Randomized Trials
in Seniors
Fries et al, Health Affairs, 1998
27
Health Improvement and Cost Reduction Programs in
Senior Populations Goals
  • Improved Self-Efficacy
  • Reduction in Health Risks
  • Increased Self-Management
  • Targeting High-Risk Persons
  • Targeting Chronic Disease
  • Advance Directives Humanizing the Last Year

28
Parameters of Programs that Improve Health and
Save Money
  • Program cost 100/year or less (medical costs per
    senior per year 6,000). Design ROI 51
  • Multiple interventions in one
  • Multiple contacts through the year
  • Tailored interventions - to each his or her own
    health improvement program
  • Not doctor/hospital/one-on-one based too
    expensive
  • Computer-driven, mail (and increasingly Web)
    delivered
  • Focus on big, modifiable health and cost issues

29
Senior Risk Reduction Program
  • Medicare Demonstration Program 2007-2010
  • Tailored health improvement and cost reduction
    programs (HRA based)
  • Potential established by RAND randomized trial
    design by MedSTAT
  • Five interventions best in class, two control
    groups, three years, 85,000 subjects, independent
    assessment of results
  • Goalshealth up, risks down, costs neutral or
    down a new Medicare benefit

30
ConclusionsTheory, Longitudinal Studies,
Population Surveys, and Randomized Trials
document that
  • Disability has been decreasing by 2 or more per
    year in the U.S.for at least 10 years. Mortality
    rates are decreasing at only 1 a year,
    documenting Compression of Morbidity
  • Health enhancement programs can improve health
    and reduce costs in mature adult populations
  • The Senior Risk Reduction Demonstration is a
    randomized controlled trial which could lead to
    better senior health and lower medical costs
  • Further Compression of Morbidity is feasible but
    not inevitable.

31
HOW CAN IT BE ACHIEVED?
  • Self-Efficacy
  • Health Policies
  • Targeted Postponement of Morbidity
  • Behavioral Health Risk Reduction
  • Medical Primary Prevention
  • Medical Secondary Prevention
  • Social and Environmental Policies

32
PRIMARY PREVENTION
  • Smoking
  • Passive Smoking
  • Inactivity
  • Obesity
  • Lipids
  • Inflammation
  • Salt
  • Fiber
  • Screeningsmam, col, pap, bp, eye, bmd
  • Alcohol
  • Caffeine
  • Sun
  • Seat Belts
  • Vehicles
  • Highways
  • Aspirin
  • Pollution
  • Vaccines

33
SECONDARY PREVENTION
  • Aspirin
  • Hypertensive control
  • Lipid control
  • Diabetes control
  • Beta blockers
  • Bone strengthening
  • Fall Prevention
  • Self-management
  • Medical errors
  • Plus Primary prevention approaches

34
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com